BCL-2 drugs for Chronic Lymphocytic Leukemia
3 tracked BCL-2 drugs in the Chronic Lymphocytic Leukemia race. The class explanation lives on the BCL-2 page; the full indication pipeline across every mechanism is on the Chronic Lymphocytic Leukemia page.
1 approved / phase 41 Phase 31 Phase 2/3
Head-to-head evidence: Mesutoclax vs Venetoclax · Sonrotoclax vs Venetoclax